Quantifying Nanomolar Levels of Nitrite in Biological Samples by HPLC-Griess Method: Special Reference to Arterio-Venous Difference in vivo

DOI Web Site 3 Citations 54 References Open Access
  • Ishibashi Takaharu
    Department of Pharmacology, School of Nursing, Kanazawa Medical University Department of Pharmacology, School of Medicine, Kanazawa Medical University
  • Miwa Tomoko
    Department of Pharmacology, School of Medicine, Kanazawa Medical University
  • Shinkawa Ikumi
    Department of Pharmacology, School of Medicine, Kanazawa Medical University
  • Nishizawa Naoki
    Department of Pharmacology, School of Medicine, Kanazawa Medical University
  • Nomura Mihoko
    Department of Pharmacology, School of Medicine, Kanazawa Medical University
  • Yoshida Junko
    Department of Pharmacology, School of Medicine, Kanazawa Medical University
  • Kawada Tomie
    Department of Clinical Pharmacy, Faculty of Pharmacy, Musashino University
  • Nishio Matomo
    Department of Pharmacology, School of Medicine, Kanazawa Medical University

Search this article

Description

Nitrite (NO2-) is assumed to play an important role in regulation of vascular tone as a reservoir of nitric oxide (NO). To examine its physiological contribution, however, a sensitive method is required for determination of the true level of NO2- in biological samples. To this end, practical consideration to avoid NO2- contamination through the quantification procedure is important. We present here a highly sensitive and accurate method for determining NO2- in plasma by improving the HPLC-Griess system with minimal NO2- contamination in the samples. The system achieved high sensitivity (detection limit of 2 nM and sensitivity to 1 nM) and complete separation of the NO2- signal peak by modifying the system setup and mobile phase. Using this method, we achieved acceptable quantification of low NO2- levels in plasma. Deproteinization by ultrafiltration and exposure to atmosphere before measurement were identified as the major sources of NO2- contamination during sample processing. We addressed these issues by the use of methanol for deproteinization and gas-tight caps. These countermeasures allowed us to detect small arterio-venous NO2- differences in rabbit plasma that may indicate kinetic difference of NO2- in a small number of samples (n = 6). This difference became prominent when NO2- or a NO releasing agent, NOR1, was intravenously applied. Our results indicate that application of a sensitive method with careful handling is important for accurate determination of NO2- and that our method is applicable for further examination of the kinetic features of NO2- in vivo.

Journal

Citations (3)*help

See more

References(54)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top